Roprestimin/Romigrastim Price Analysis in 2025: How Patients Plan for Treatment Costs

Romiplostim is a drug used to treat idiopathic thrombocytopenia (ITP). Idiopathic thrombocytopenic purpura is an immune disease in which the patient's immune system mistakenly attacks and destroys one's own platelets, resulting in a decrease in platelet count and an increased risk of bleeding. Roprostim is a recombinant protein whose mechanism of action is to stimulate the production of platelets by stimulating megakaryocytes in the bone marrow.

The drug binds to the thrombopoietin (THPO) receptor, mimicking the effects of natural thrombopoietin, thereby activating signaling pathways related to platelet production. By increasing the number and maturation of megakaryocytes, roplastin can effectively increase the production and release of platelets and help patients restore normal platelet levels.

Roprostim is usually administered by subcutaneous injection, and the dose is adjusted according to the patient's specific condition. During the treatment process, doctors need to regularly monitor the patient's platelet level to ensure the treatment effect and adjust the medication regimen in a timely manner. At the same time, because this drug may cause some side effects, including but not limited to headaches, joint pain, and injection site reactions, the patient's overall health needs to be carefully evaluated when using it.

The original drug of Roprostim for injection is already available in the domestic market, and the drug has also been included in the scope of medical insurance. However, it may be difficult to purchase due to its short time on the market. In the Hong Kong market, the price of the original research version is about more than 9,000 yuan per piece, while the Hong Kong version may be more than 8,000 yuan per piece (the specific price may fluctuate due to the impact of exchange rates). Overseas, there are European and German versions of the original drug Roplastin. The price of each drug is about 10,000 yuan (also affected by the exchange rate). Although the prices are different, the ingredients of these drugs are basically the same. Currently, there are no generic drugs of Ropremilast on the overseas market.

Reference materials:https://en.wikipedia.org/wiki/Romiplostim